2nd Strategic Partnerships for Drug Repurposing Forum - Hyatt Regency Boston Harbor

2nd Strategic Partnerships for Drug Repurposing Forum
October 26 - 27, 2017
Hyatt Regency Boston Harbor
Boston, MA

Understand the importance of drug repurposing, repositioning and rescue through innovative strategies

2nd Strategic Partnerships for Drug Repurposing Forum – 2nd Strategic Partnerships for Drug Repurposing Forum

Drug repurposing, repositioning, and rescue all allow pharmaceutical companies to maintain or increase the lifecycle of drugs and decrease the expense of the full research and development process. In today’s society, life science organizations not only develop strategies and methods to help find cures for diseases; they also utilize data from past clinical trials to uncover potential new indications to repurpose, reposition or rescue a drug. With more than 7,000 known diseases worldwide, drug repurposing provides an alternative route for companies to provide treatments to patients faster.

At ExL’s 2nd Strategic Partnership for Drug Repurposing Forum you will hear the latest indications for repurposing, rescuing and repositioning existing drugs to explore the newest innovations. Attendees will learn about the different resources available to them, including public-private partnerships, foundations, patient advocacy groups, universities and other funding partners. Come network and build partnerships with all stakeholders.

 Top Five Reasons to Attend

  1. Engage in case studies and panel discussions on how to excel in searching for drug repurposing opportunities and uncover new indications for existing drugs
  2. Cover new methods in the pipeline by using innovative strategies to discover new therapeutic uses for existing molecules
  3. Identify new technologies used for the evaluation of repurposed drugs
  4. Explore how to develop strategic partnerships between the government, universities, patient advocacy groups, foundations, and sponsors
  5. Understand the FDA regulations (505b) for New Drug Applications, the legal framework and intellectual property laws surrounding drug repurposing

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations; patient organizations; and nonprofit foundations with responsibilities in the following areas:

  • Drug Repurposing
  • Indication Expansion
  • Strategic Partnerships and Alliances
  • Global Commercialization/Strategy
  • Program and Portfolio Development
  • Translational Medicine
  • Strategy and Portfolio Solutions
  • Corporate Strategy
  • Market Access
  • Asset Management
  • Advanced Brand Strategies
  • Research and Development
  • Scientific/Clinical Development
  • Regulatory Affairs
  • Bioinformatics
  • Big Data Analytics
  • Patient Networks

This event is also of interest to professionals involved in:

    • Clinical Operations/Clinical Outsourcing
    • Trauma Therapeutics
    • Drug Delivery/Discovery
  • Product Development
  • Clinical Operations
live chat software